Main Street Financial Solutions LLC Raises Position in iShares Biotechnology ETF (NASDAQ:IBB)

Main Street Financial Solutions LLC lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,152 shares of the financial services provider’s stock after acquiring an additional 150 shares during the quarter. Main Street Financial Solutions LLC’s holdings in iShares Biotechnology ETF were worth $1,187,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of the stock. Jane Street Group LLC acquired a new position in iShares Biotechnology ETF during the 1st quarter worth approximately $14,386,000. Cetera Investment Advisers grew its stake in shares of iShares Biotechnology ETF by 689.4% during the first quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after purchasing an additional 79,541 shares in the last quarter. State of Michigan Retirement System increased its holdings in iShares Biotechnology ETF by 150.0% in the second quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock valued at $17,158,000 after buying an additional 75,000 shares during the last quarter. Aristides Capital LLC purchased a new position in iShares Biotechnology ETF in the second quarter valued at $9,180,000. Finally, Sanctuary Advisors LLC acquired a new stake in iShares Biotechnology ETF in the second quarter valued at $8,118,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Down 0.4 %

NASDAQ:IBB opened at $143.80 on Thursday. iShares Biotechnology ETF has a 1 year low of $116.70 and a 1 year high of $150.57. The stock has a 50-day simple moving average of $144.78 and a 200-day simple moving average of $141.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.